← Browse by Condition
Medical Condition
esophageal squamous cell carcinoma
Total Trials
18
Recruiting Now
18
Trial Phases
Phase 2, Phase 3, Phase 1
ClinicalMetric tracks all active clinical trials for esophageal squamous cell carcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — esophageal squamous cell carcinoma Clinical Trials
How many clinical trials are currently recruiting for esophageal squamous cell carcinoma?
ClinicalMetric currently tracks 18 actively recruiting clinical trials for esophageal squamous cell carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 18. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for esophageal squamous cell carcinoma?
esophageal squamous cell carcinoma research spans Phase 1 (2 trials), Phase 2 (10 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a esophageal squamous cell carcinoma clinical trial?
Eligibility criteria for esophageal squamous cell carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 2 10
Phase 3 2
Top Sponsors
2 trials
2 trials
2 trials
2 trials
1 trial
Recruiting Clinical Trials
NCT05740995
Recruiting
Enrollment
40 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
NCT06988956 Phase 2
Recruiting
Enrollment
95 pts
Location
China
Sponsor
The First Affiliated Hospital ...
NCT07554521 Phase 2
Recruiting
Enrollment
30 pts
Location
United States
Sponsor
BeOne Medicines
NCT07699185 Phase 2
Recruiting
Enrollment
336 pts
Location
China
Sponsor
Tongji Hospital
NCT05252078 Phase 2
Recruiting
Enrollment
30 pts
Location
China
Sponsor
Jiangxi Provincial Cancer Hosp...
NCT06190782 Phase 3
Recruiting
Enrollment
354 pts
Location
China
Sponsor
Fudan University
NCT06329869 Phase 2
Recruiting
Enrollment
35 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
NCT06602843
Recruiting
Enrollment
70 pts
Location
China
Sponsor
Anhui Provincial Hospital
NCT07088354
Recruiting
Enrollment
300 pts
Location
China
Sponsor
Tongji Hospital
NCT07505186 Phase 2
Recruiting
Enrollment
45 pts
Location
China
Sponsor
Second Affiliated Hospital, Zh...
NCT07016724 Phase 2
Recruiting
Enrollment
208 pts
Location
China
Sponsor
The First Affiliated Hospital ...
NCT06408584
Recruiting
Enrollment
25 pts
Location
China
Sponsor
Anhui Provincial Hospital
NCT07858630
Recruiting
Enrollment
500 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
NCT06084481 Phase 1
Recruiting
Enrollment
325 pts
Location
United States, Austr...
Sponsor
AbbVie
NCT06637163 Phase 2
Recruiting
Enrollment
100 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
NCT07437898 Phase 2
Recruiting
Enrollment
42 pts
Location
China
Sponsor
The Affiliated Hospital of Put...
NCT05319730 Phase 1, Phase 2
Recruiting
Enrollment
230 pts
Location
United States, Brazi...
Sponsor
Merck Sharp & Dohme LLC
NCT06563869 Phase 3
Recruiting
Enrollment
40 pts
Location
China
Sponsor
The First Affiliated Hospital ...
Related Conditions
neoadjuvant chemoimmunotherapy (1) advanced unresectable gastric adenocarcinoma (1) advanced gastroesophageal adenocarcinoma (1) esophageal neoplasms (1) esophageal diseases (1) gastrointestinal neoplasms (1) gastrointestinal diseases (1) digestive system neoplasms (1) digestive system diseases (1) neoplasms by site (1) neoplasms by histologic type (1) neoplasms squamous cell (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology